Insights

Expansion Potential BMS is actively expanding its physical footprint with a new 427,000-square-foot R&D hub in California and a large-scale Texas manufacturing investment, signaling opportunities to offer collaboration on translational medicine, clinical research support, and contract development or manufacturing services.

Pipeline Commercialization The company maintains a sustainable therapy pipeline across oncology, hematology, immunology, cardiovascular disease, and fibrosis, creating multiple touchpoints for potential licensing, co-development, or strategic partnerships to accelerate bringing new therapies to market.

Data and Tech Enablement BMS emphasizes translational medicine and data analytics to optimize patient-fit therapies, presenting openings for analytics platforms, real-world evidence partnerships, and digital health solutions to enhance trial design, biomarker research, and patient recruitment.

Strategic Partnerships Collaborations such as the BARBARA Alliance funding and ongoing external partnerships underscore a readiness to co-invest in trials and speed recruitment, suggesting opportunities for joint ventures, grant-supported studies, and shared infrastructure projects.

Clinical and Commercial Scale With a substantial revenue base and ongoing launches like Sotyktu for psoriatic arthritis, there is potential to offer specialty manufacturing, supply chain optimization, and commercial analytics services to support market access, payer strategy, and sales force optimization.

Similar companies to Bristol Myers Squibb

Bristol Myers Squibb Tech Stack

Bristol Myers Squibb uses 8 technology products and services including Apache Spark, Tableau, Hyperion, and more. Explore Bristol Myers Squibb's tech stack below.

Media & News

Bristol Myers Squibb's Email Address Formats

Bristol Myers Squibb uses at least 4 email formats:
Bristol Myers Squibb Email FormatsExamplePercentage
First.Last@bms.comJohn.Doe@bms.com
91%
LastF@bms.comDoeJ@bms.com
5%
First@bms.comJohn@bms.com
2%
Last.First@bms.comDoe.John@bms.com
2%

Frequently Asked Questions

What is Bristol Myers Squibb's phone number?

Minus sign iconPlus sign icon
You can contact Bristol Myers Squibb's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Bristol Myers Squibb's stock symbol?

Minus sign iconPlus sign icon
Bristol Myers Squibb is a publicly traded company; the company's stock symbol is BMY.

What is Bristol Myers Squibb's official website and social media links?

Minus sign iconPlus sign icon
Bristol Myers Squibb's official website is bms.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Bristol Myers Squibb generate?

Minus sign iconPlus sign icon
As of October 2026, Bristol Myers Squibb's annual revenue is estimated to be $10B+.

What is Bristol Myers Squibb's SIC code and NAICS code?

Minus sign iconPlus sign icon
Bristol Myers Squibb's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Bristol Myers Squibb have currently?

Minus sign iconPlus sign icon
As of October 2026, Bristol Myers Squibb has approximately 39K employees across 6 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: E. N., CPO: D. D. and Chief Financial Officer: A. S. Explore Bristol Myers Squibb's employee directory with LeadIQ.

What industry does Bristol Myers Squibb belong to?

Minus sign iconPlus sign icon
Bristol Myers Squibb operates in the Pharmaceutical Manufacturing industry.

What technology does Bristol Myers Squibb use?

Minus sign iconPlus sign icon
Bristol Myers Squibb's tech stack includes Apache Spark, Tableau, Hyperion, Talend, Redis, Microsoft Intune, VMware vCenter and Atlassian Confluence.

What is Bristol Myers Squibb's email format?

Minus sign iconPlus sign icon
Bristol Myers Squibb's email format typically follows the pattern of First.Last@bms.com. Find more Bristol Myers Squibb email formats with LeadIQ.

How much funding has Bristol Myers Squibb raised to date?

Minus sign iconPlus sign icon
As of October 2026, Bristol Myers Squibb has raised $29B in funding. The last funding round occurred on Mar 14, 2024 for $13B.
Bristol Myers Squibb logo

Bristol Myers Squibb

Pharmaceutical ManufacturingNew Jersey, United States10001+ Employees

Bristol Myers Squibb is a global pharmaceutical manufacturer focused on developing therapies in oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company aims to translate scientific advances into patient benefit by building a durable pipeline and using translational medicine and data analytics to tailor treatments to the right patient at the right time. Its work spans research and collaboration across diverse teams, with a foundation dedicated to health equity. 

Headquartered in Lawrence Township, New Jersey, it operates in the global pharmaceutical industry as a large-scale provider of medicines. In June 2026, the company announced the appointment of Mayada Al-Ahmad as General Manager for Saudi Arabia and Gulf Countries, reflecting leadership expansion in that region.

Section iconCompany Overview

Phone number
Website
bms.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
BMY
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
10001+

Section iconFunding & Financials

  • $29B

    Bristol Myers Squibb has raised a total of $29B of funding over 5 rounds. Their latest funding round was raised on Mar 14, 2024 in the amount of $13B as a Post IPO Debt.

  • $10B+

    Bristol Myers Squibb's revenue is estimated to be in the range of $10B+

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.